Appeals

We announce the release of a new dashboard designed to make New York's external appeal data more accessible to patients, advocates, policymakers, and researchers.

We share an interactive tool highlighting the critical role denials and appeals play in financial incentives in U.S. health insurance.

Announcing a submission of a Freedom of Information Act public records request for Medicare data, prepared in collaboration with the Data Liberation Project.

We analyze data from the CMS Medicare Part C and D Qualified Independent Contractor appeal database.

We look into demographic trends in two California databases documenting outcomes of external appeals of health insurance denials.

A guided tour of an insurance denial appeal. We walk through the life cycle of an appeal of coverage denial for the Anser ADA level test for Humira/Adalimumab levels. Part 7: Final Decision.

A guided tour of an insurance denial appeal. We walk through the life cycle of an appeal of coverage denial for the Anser ADA level test for Humira/Adalimumab levels. Part 6: External Appeal.

A guided tour of an insurance denial appeal. We walk through the life cycle of an appeal of coverage denial for the Anser ADA level test for Humira/Adalimumab levels. Part 5: Initial Appeal Response.

A guided tour of an insurance denial appeal. We walk through the life cycle of an appeal of coverage denial for the Anser ADA level test for Humira/Adalimumab levels. Part 4: Initial Appeal.

A guided tour of an insurance denial appeal. We walk through the life cycle of an appeal of coverage denial for the Anser ADA level test for Humira/Adalimumab levels. Part 3: Appeal Research.

A guided tour of an insurance denial appeal. We walk through the life cycle of an appeal of coverage denial for the Anser ADA level test for Humira/Adalimumab levels. Part 2: Denial.

A guided tour of an insurance denial appeal. We walk through the life cycle of an appeal of coverage denial for the Anser ADA level test for Humira/Adalimumab levels. Part 1: Background.